Atlas Trials

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Clinical trial NCT02669017 · COMPLETED

Trial details

NCT number
NCT02669017
Sponsor
ADC Therapeutics S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Hodgkin LymphomaBurkitt's LymphomaChronic Lymphocytic LeukemiaLymphoma, Large B-Cell, DiffuseLymphoma, FollicularLymphoma, Mantle-CellLymphoma, Marginal ZoneWaldenstrom MacroglobulinemiaPrimary Mediastinal B-cell Lymphoma
Start date
2016-03-01
Primary completion
2019-02-21
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.